President Trump this week said that insurers would cover the costs of testing and treatment. That's not quite true.

Many states are exploring implementing a public option, and once one is successful, others may well follow.

In the latest debate, top contenders for the Democratic presidential nomination sparred over the price tag on health care reform.

The latest debate featured now-familiar themes such as Medicare for All versus a public option and the cost of prescription drugs.

The statistic, cited by Sen. Elizabeth Warren in a recent Instagram post, might make her Medicare for All price tag more palatable.

There's a lot left to be answered before policymakers and voters can come close to understanding the full impact.

Kaiser Health News teamed up with Politifact to evaluate a recent claim from the Trump administration about drug prices.

Even official Medicare for All co-sponsors are at the edging toward a more incremental approach, “Medicare for America."